{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:07:34Z","timestamp":1790881654650,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.euros.2026.03.006","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:48:03Z","timestamp":1774039683000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Familial Risks in 317,000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding Diagnostics"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-3316","authenticated-orcid":false,"given":"Kari","family":"Hemminki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantisek","family":"Zitricky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"F\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akseli","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.03.006_b0005","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.3390\/cancers13174385","article-title":"Familial risks and proportions describing population landscape of familial cancer","volume":"13","author":"Hemminki","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.euros.2026.03.006_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077738","article-title":"Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study","volume":"386","author":"Vaccarella","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2026.03.006_b0015","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.3390\/cancers15164132","article-title":"Conditional survival in prostate cancer in the Nordic countries elucidates the timing of improvements","volume":"15","author":"Zitricky","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.euros.2026.03.006_b0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bju.13364","article-title":"Trends in stage-specific incidence of prostate cancer in Norway, 1980\u20132010: a population-based study","volume":"118","author":"M\u00f8ller","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.03.006_b0025","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/jnci\/dji338","article-title":"Familial risk of cancer shortly after diagnosis of the first familial tumor","volume":"97","author":"Bermejo","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euros.2026.03.006_b0030","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/djq265","article-title":"Effects of prostate-specific antigen testing on familial prostate cancer risk estimates","volume":"102","author":"Bratt","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euros.2026.03.006_b0035","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/ijc.24795","article-title":"The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies","volume":"126","author":"Hemminki","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euros.2026.03.006_b0040","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1634\/theoncologist.2009-0132","article-title":"Age at diagnosis and age at death in familial prostate cancer","volume":"14","author":"Brandt","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.euros.2026.03.006_b0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2010.02.002","article-title":"Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members","volume":"58","author":"Brandt","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.006_b0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/annonc\/mdr056","article-title":"Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer","volume":"23","author":"Brandt","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euros.2026.03.006_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003616","article-title":"Risk of prostate cancer in relatives of prostate cancer patients in Sweden: a nationwide cohort study","volume":"18","author":"Xu","year":"2021","journal-title":"PLOS Med"},{"key":"10.1016\/j.euros.2026.03.006_b0060","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2012.02.032","article-title":"Concordance of tumor differentiation among brothers with prostate cancer","volume":"62","author":"Jansson","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.006_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071082","article-title":"Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit","volume":"381","author":"Vickers","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2026.03.006_b0070","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100:1\u2013441."},{"key":"10.1016\/j.euros.2026.03.006_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eururo.2021.12.011","article-title":"Defining the impact of family history on detection of high-grade prostate cancer in a large multi-institutional cohort","volume":"82","author":"Clements","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.006_b0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2022.11.019","article-title":"Family history of prostate cancer and survival outcomes in the UK genetic prostate cancer study","volume":"83","author":"Brook","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.006_b0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41698-022-00282-8","article-title":"An appraisal of genetic testing for prostate cancer susceptibility","volume":"6","author":"Finch","year":"2022","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.euros.2026.03.006_b0090","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","article-title":"Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021","volume":"80","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.006_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euros.2024.08.011","article-title":"Hereditary and familial traits in urological cancers and their underlying genes","volume":"69","author":"Hemminki","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.03.006_b0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41585-022-00580-7","article-title":"Germline testing and genetic counselling in prostate cancer","volume":"19","author":"Russo","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euros.2026.03.006_b0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.03.006_b0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/genes11030314","article-title":"Inherited DNA repair gene mutations in men with lethal prostate cancer","volume":"11","author":"Rantapero","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.euros.2026.03.006_b0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/pros.24918","article-title":"Germline testing for prostate cancer patients: evidence-based evaluation of genes recommended by NCCN guidelines","volume":"85","author":"Xu","year":"2025","journal-title":"Prostate"},{"key":"10.1016\/j.euros.2026.03.006_b0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.euo.2024.02.003","article-title":"Identification of genes with rare loss of function variants associated with aggressive prostate cancer and survival","volume":"7","author":"Saunders","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2026.03.006_b0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/bju.15444","article-title":"Assessment of prostate-specific antigen screening: an evidence-based report by the German Institute for quality and efficiency in health care","volume":"129","author":"Paschen","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.03.006_b0130","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1200\/JCO.2007.13.3355","article-title":"Concordance of survival in family members with prostate cancer","volume":"26","author":"Hemminki","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2026.03.006_b0135","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMcp2209151","article-title":"Screening for prostate cancer","volume":"388","author":"Pinsky","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.03.006_b0140","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.34295","article-title":"Adherence to a risk-adapted screening strategy for prostate cancer: first results of the PROBASE trial","volume":"152","author":"Krilaviciute","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euros.2026.03.006_b0145","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.2024.3841","article-title":"Prostate cancer screening with PSA, kallikrein panel, and MRI: the ProScreen randomized trial","volume":"331","author":"Auvinen","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2026.03.006_b0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eururo.2024.01.017","article-title":"Prostate Cancers in the prostate-specific antigen Interval of 1.8\u20133 ng\/ml: results from the G\u00f6teborg-2 prostate cancer screening trial","volume":"86","author":"M\u00f6ller","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.006_b0155","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jmg.2004.022731","article-title":"Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans","volume":"41","author":"Hemminki","year":"2004","journal-title":"J Med Genet"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:45:30Z","timestamp":1779306330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"alternative-id":["S2666168326000480"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.03.006","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial Risks in 317,000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding Diagnostics","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}